Galectin Therapeutics (GALT) Return on Assets (2011 - 2026)

Galectin Therapeutics' Return on Assets history runs 16 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Assets rose 2.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (up 2.0% YoY), while the FY2025 annual figure was 0.01%, up 1.0% from the prior year.
• Return on Assets was 0.01% for Q1 2026 at Galectin Therapeutics, up from 0.02% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.01% in Q1 2022 to a low of 0.03% in Q1 2025.
• Historically, Return on Assets has averaged 0.02% across 5 years, with a median of 0.02% in 2025.
• The sharpest annual moves came in 2025 and 2026: Return on Assets fell 2 bps in 2025, then gained 2 bps in 2026.
• A 5-year view of Return on Assets shows it stood at 0.02% in 2022, then gained by 20 bps to 0.02% in 2023, then declined by 27 bps to 0.02% in 2024, then rose by 18 bps to 0.02% in 2025, then climbed by 20 bps to 0.01% in 2026.
• The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.02% (Q4 2025), and 0.03% (Q3 2025), per Business Quant data.